USA Financial Formulas’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-478
Closed -$28K 403
2022
Q1
$28K Sell
478
-36
-7% -$2.19K 0.03% 148
2021
Q4
$39K Buy
+514
New +$32.9K 0.03% 156
2016
Q3
Sell
-24,948
Closed -$449K 280
2016
Q2
$449K Buy
24,948
+8,565
+52% +$159K 0.12% 137
2016
Q1
$303K Sell
16,383
-506
-3% -$8.03K 0.1% 64
2015
Q4
$249K Buy
+16,889
New +$254K 0.1% 90

Other funds holding MXL

USA Financial Formulas's MXL Position: Q2 2022 in Review

USA Financial Formulas sold out of MaxLinear (MXL) in Q2 2022, closing a stake of 478 shares — an estimated $28K sold.

USA Financial Formulas first reported a position in MXL in Q4 2015 and held it in 5 quarters. The position peaked at $449K in Q2 2016. 281 funds tracked by Wall St. Rank hold MXL as of Q2 2022.

  • USA Financial Formulas reported no remaining MaxLinear position as of Q2 2022 after selling out during the quarter.
  • USA Financial Formulas sold 478 MaxLinear shares in Q2 2022, an estimated $28K.
  • USA Financial Formulas first reported a position in MaxLinear in Q4 2015 and held it in 5 quarters.
  • USA Financial Formulas's MaxLinear position peaked at $449K in Q2 2016.
  • 281 funds tracked by Wall St. Rank held MaxLinear as of Q2 2022.

Based on USA Financial Formulas's 13F filing for Q2 2022, filed 15 Aug 2022.